Impact of Anemia on Clinical Outcomes of Patients With ST-Segment Elevation Myocardial Infarction in Relation to Gender and Adjunctive Antithrombotic Therapy (from the HORIZONS-AMI Trial)

American Journal of Cardiology

Volumn 105, Issue 10, 2010, Pages 1385-1394

  Tsujita, Kenichi ^a   Nikolsky, Eugenia ^a   Lansky, Alexandra J ^a   Dangas, George ^a   Fahy, Martin ^a   Brodie, Bruce R ^b   Dudek, Dariusz ^c   Möckel, Martin ^d   Ochala, Andrzej ^e   Mehran, Roxana ^a   Stone, Gregg W ^a  

^a NewYork Presbyterian Hospital   (United States)

^b MOSES H CONE MEMORIAL HOSPITAL   (United States)

^c JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^d CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^e MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; ANTICOAGULANT AGENT; CLOPIDOGREL; EPTIFIBATIDE; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN; HIRULOG; PACLITAXEL;

ADULT; AGED; ANEMIA; ARTICLE; BARE METAL STENT; BLEEDING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG ELUTING STENT; FEMALE; HUMAN; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; PREDICTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEX DIFFERENCE; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; TREATMENT RESPONSE;

AGED; ANEMIA; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; COMBINED MODALITY THERAPY; DRUG THERAPY, COMBINATION; ELECTROCARDIOGRAPHY; FEMALE; FIBRINOLYTIC AGENTS; FOLLOW-UP STUDIES; HEPARIN; HIRUDINS; HOSPITAL MORTALITY; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; NEOADJUVANT THERAPY; PEPTIDE FRAGMENTS; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; PROBABILITY; PROPORTIONAL HAZARDS MODELS; RECOMBINANT PROTEINS; RISK ASSESSMENT; SEX FACTORS; SURVIVAL ANALYSIS; THROMBOLYTIC THERAPY; TREATMENT OUTCOME;

EID: 77951878249     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2010.01.001     Document Type: Article

References (28)

1. Wu W.C., Rathore S.S., Wang Y., Radford M.J., and Krumholz H.M. Blood transfusion in elderly patients with acute myocardial infarction. N Engl J Med 345 (2001) 1230-1236
2. Al Falluji N., Lawrence-Nelson J., Kostis J.B., Lacy C.R., Ranjan R., and Wilson A.C. Effect of anemia on 1-year mortality in patients with acute myocardial infarction. Am Heart J 144 (2002) 636-641
3. Nikolsky E., Aymong E.D., Halkin A., Grines C.L., Cox D.A., Garcia E., Mehran R., Tcheng J.E., Griffin J.J., Guagliumi G., Stuckey T., Turco M., Cohen D.A., Negoita M., Lansky A.J., and Stone G.W. Impact of anemia in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: analysis from the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trial. J Am Coll Cardiol 44 (2004) 547-553
4. Sabatine M.S., Morrow D.A., Giugliano R.P., Burton P.B., Murphy S.A., McCabe C.H., Gibson C.M., and Braunwald E. Association of hemoglobin levels with clinical outcomes in acute coronary syndromes. Circulation 111 (2005) 2042-2049
5. Stone G.W., Witzenbichler B., Guagliumi G., Peruga J.Z., Brodie B.R., Dudek D., Kornowski R., Hartmann F., Gersh B.J., Pocock S.J., Dangas G., Wong S.C., Kirtane A.J., Parise H., and Mehran R. Bivalirudin during primary PCI in acute myocardial infarction. N Engl J Med 358 (2008) 2218-2230
6. World Health Organization. Nutritional anaemias. Report of a WHO scientific group. World Health Organ Tech Rep Ser 405 (1968) 5-37
7. Cockcroft D.W., and Gault M.H. Prediction of creatinine clearance from serum creatinine. Nephron 16 (1976) 31-41
8. Cutlip D.E., Windecker S., Mehran R., Boam A., Cohen D.J., van Es G.A., Steg P.G., Morel M.A., Mauri L., Vranckx P., McFadden E., Lansky A., Hamon M., Krucoff M.W., and Serruys P.W. Clinical end points in coronary stent trials: a case for standardized definitions. Circulation 115 (2007) 2344-2351
9. Karkouti K., Wijeysundera D.N., and Beattie W.S. Risk associated with preoperative anemia in cardiac surgery: a multicenter cohort study. Circulation 117 (2008) 478-484
10. Riva E., Tettamanti M., Mosconi P., Apolone G., Gandini F., Nobili A., Tallone M.V., Detoma P., Giacomin A., Clerico M., Tempia P., Guala A., Fasolo G., and Lucca U. Association of mild anemia with hospitalization and mortality in the elderly: the Health and Anemia population-based study. Haematologica 94 (2009) 22-28
11. Ezekowitz J.A., McAlister F.A., and Armstrong P.W. Anemia is common in heart failure and is associated with poor outcomes: insights from a cohort of 12 065 patients with new-onset heart failure. Circulation 107 (2003) 223-225
12. Anderson R.D., White H.D., Ohman E.M., Wagner G.S., Krucoff M.W., Armstrong P.W., Weaver W.D., Gibler W.B., Stebbins A.L., Califf R.M., and Topol E.J. Predicting outcome after thrombolysis in acute myocardial infarction according to ST-segment resolution at 90 minutes: a substudy of the GUSTO-III trial. Am Heart J 144 (2002) 81-88
13. Becker R.C., Terrin M., Ross R., Knatterud G.L., Desvigne-Nickens P., Gore J.M., and Braunwald E. Thrombolysis In Myocardial Infarction Investigators. Comparison of clinical outcomes for women and men after acute myocardial infarction. Ann Intern Med 120 (1994) 638-645
14. Best P.J., Lennon R., Ting H.H., Bell M.R., Rihal C.S., Holmes D.R., and Berger P.B. The impact of renal insufficiency on clinical outcomes in patients undergoing percutaneous coronary interventions. J Am Coll Cardiol 39 (2002) 1113-1119
15. Gottlieb S.S., McCarter R.J., and Vogel R.A. Effect of beta-blockade on mortality among high-risk and low-risk patients after myocardial infarction. N Engl J Med 339 (1998) 489-497
16. Marenzi G., Lauri G., Assanelli E., Campodonico J., De Metrio M., Marana I., Grazi M., Veglia F., and Bartorelli A.L. Contrast-induced nephropathy in patients undergoing primary angioplasty for acute myocardial infarction. J Am Coll Cardiol 44 (2004) 1780-1785
17. Feit F., Voeltz M.D., Attubato M.J., Lincoff A.M., Chew D.P., Bittl J.A., Topol E.J., and Manoukian S.V. Predictors and impact of major hemorrhage on mortality following percutaneous coronary intervention from the REPLACE-2 trial. Am J Cardiol 100 (2007) 1364-1369
18. Moscucci M., Fox K.A., Cannon C.P., Klein W., Lopez-Sendon J., Montalescot G., White K., and Goldberg R.J. Predictors of major bleeding in acute coronary syndromes: the Global Registry of Acute Coronary Events (GRACE). Eur Heart J 24 (2003) 1815-1823
19. Roy P., Bonello L., Torguson R., de Labriolle A., Lemesle G., Slottow T.L., Steinberg D.H., Kaneshige K., Xue Z., Satler L.F., Kent K.M., Suddath W.O., Pichard A.D., Lindsay J., and Waksman R. Impact of "nuisance" bleeding on clopidogrel compliance in patients undergoing intracoronary drug-eluting stent implantation. Am J Cardiol 102 (2008) 1614-1617
20. Rao S.V., Jollis J.G., Harrington R.A., Granger C.B., Newby L.K., Armstrong P.W., Moliterno D.J., Lindblad L., Pieper K., Topol E.J., Stamler J.S., and Califf R.M. Relationship of blood transfusion and clinical outcomes in patients with acute coronary syndromes. JAMA 292 (2004) 1555-1562
21. Yang X., Alexander K.P., Chen A.Y., Roe M.T., Brindis R.G., Rao S.V., Gibler W.B., Ohman E.M., and Peterson E.D. The implications of blood transfusions for patients with non-ST-segment elevation acute coronary syndromes: results from the CRUSADE National Quality Improvement Initiative. J Am Coll Cardiol 46 (2005) 1490-1495
22. Kahn R.C., Zaroulis C., Goetz W., and Howland W.S. Hemodynamic oxygen transport and 2,3-diphosphoglycerate changes after transfusion of patients in acute respiratory failure. Intensive Care Med 12 (1986) 22-25
23. Pawloski J.R., and Stamler J.S. Nitric oxide in RBCs. Transfusion 42 (2002) 1603-1609
24. Tsai A.G., Cabrales P., and Intaglietta M. Microvascular perfusion upon exchange transfusion with stored red blood cells in normovolemic anemic conditions. Transfusion 44 (2004) 1626-1634
25. Twomley K.M., Rao S.V., and Becker R.C. Proinflammatory, immunomodulating, and prothrombotic properties of anemia and red blood cell transfusions. J Thromb Thrombolysis 21 (2006) 167-174
26. Guralnik J.M., Eisenstaedt R.S., Ferrucci L., Klein H.G., and Woodman R.C. Prevalence of anemia in persons 65 years and older in the United States: evidence for a high rate of unexplained anemia. Blood 104 (2004) 2263-2268
27. Sempos C.T., Looker A.C., Gillum R.F., and Makuc D.M. Body iron stores and the risk of coronary heart disease. N Engl J Med 330 (1994) 1119-1124
28. Voeltz M.D., Patel A.D., Feit F., Fazel R., Lincoff A.M., and Manoukian S.V. Effect of anemia on hemorrhagic complications and mortality following percutaneous coronary intervention. Am J Cardiol 99 (2007) 1513-1517